Javascript must be enabled to continue!
Human inborn errors of immunity underlying Talaromyces marneffei infections: a multicenter, retrospective cohort study
View through CrossRef
IntroductionTalaromyces marneffei (T. marneffei) infections in children can occur secondary to inborn errors of immunity (IEIs). We aimed to investigate the clinical and genetic features of T. marneffei infection in Chinese pediatric patients.Materials and methodsWe retrospectively reviewed 18 pediatric patients with IEIs who were diagnosed with T. marneffei infections at five public hospitals in China from January 2015 to January 2023.ResultsThe common clinical features among the patients were fever, cough, and hepatomegaly. The most common severe complications included septic shock, hemophagocytic lymphohistiocytosis (HLH), and acute respiratory distress syndrome (ARDS). Three cases presented with pan-hypogammaglobulinemia, while three other cases showed heightened levels of IgM. Elevated levels of IgE were detected in five cases, and six cases exhibited decreased T lymphocyte absolute counts. Four children were diagnosed with hyperimmunoglobulin M syndrome (HIGM) due to CD40LG mutations, three cases had severe combined immunodeficiency (SCID), and five were diagnosed with hyper-IgE syndrome (HIES). Gain-of-function (GOF) mutations in STAT1 led to STAT1 GOF in four cases. One patient was diagnosed with caspase-recruitment domain (CARD9) deficiency due to a compound mutation in the CARD9 gene, while another patient was confirmed with adenosine deaminase (ADA) deficiency.ConclusionT. marneffei infections in children with IEIs induced severe systemic complications. These children commonly exhibited abnormal immunoglobulin levels in peripheral blood, and underlying IEIs associated with T. marneffei infections have enhanced our understanding of the disease.
Frontiers Media SA
Title: Human inborn errors of immunity underlying Talaromyces marneffei infections: a multicenter, retrospective cohort study
Description:
IntroductionTalaromyces marneffei (T.
marneffei) infections in children can occur secondary to inborn errors of immunity (IEIs).
We aimed to investigate the clinical and genetic features of T.
marneffei infection in Chinese pediatric patients.
Materials and methodsWe retrospectively reviewed 18 pediatric patients with IEIs who were diagnosed with T.
marneffei infections at five public hospitals in China from January 2015 to January 2023.
ResultsThe common clinical features among the patients were fever, cough, and hepatomegaly.
The most common severe complications included septic shock, hemophagocytic lymphohistiocytosis (HLH), and acute respiratory distress syndrome (ARDS).
Three cases presented with pan-hypogammaglobulinemia, while three other cases showed heightened levels of IgM.
Elevated levels of IgE were detected in five cases, and six cases exhibited decreased T lymphocyte absolute counts.
Four children were diagnosed with hyperimmunoglobulin M syndrome (HIGM) due to CD40LG mutations, three cases had severe combined immunodeficiency (SCID), and five were diagnosed with hyper-IgE syndrome (HIES).
Gain-of-function (GOF) mutations in STAT1 led to STAT1 GOF in four cases.
One patient was diagnosed with caspase-recruitment domain (CARD9) deficiency due to a compound mutation in the CARD9 gene, while another patient was confirmed with adenosine deaminase (ADA) deficiency.
ConclusionT.
marneffei infections in children with IEIs induced severe systemic complications.
These children commonly exhibited abnormal immunoglobulin levels in peripheral blood, and underlying IEIs associated with T.
marneffei infections have enhanced our understanding of the disease.
Related Results
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
S3.4d The role of NLRP3 inflammasome in host defense during Talaromyces marneffei infection
Abstract
S3.4 Free oral paper session, September 21, 2022, 4:45 PM - 6:15 PM
Talaromyces (Penicillium) marneffei (T. marneffei) ...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
Research Progress of Talaromyces Marneffei
Research Progress of Talaromyces Marneffei
Talaromyces marneffei has a very high mortality rate and is prone to devastating effects on immunocompromised people, but there is far less attention paid to diseases caused by Tal...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Maclaine Watson & Co Ltd v. Department of Trade and Industry J H Rayner (Mincing Lane) Ltd v. Department of Trade and Industry and Others, and Related Appeals
Maclaine Watson & Co Ltd v. Department of Trade and Industry J H Rayner (Mincing Lane) Ltd v. Department of Trade and Industry and Others, and Related Appeals
International organizations — Personality — Concept of international legal personality — Whether organization a legal entity distinct from its members — Whether personality of orga...
Spanish Breast Cancer Research Group (GEICAM)
Spanish Breast Cancer Research Group (GEICAM)
This section provides current contact details and a summary of recent or ongoing clinical trials being coordinated by Spanish Breast Cancer Research Group (GEICAM). Clinical trials...
PS1154 INFECTIONS IN CLL PATIENTS RECEIVING IBRUTINIB: INCIDENCE AND PREDISPOSING FACTORS
PS1154 INFECTIONS IN CLL PATIENTS RECEIVING IBRUTINIB: INCIDENCE AND PREDISPOSING FACTORS
Background:Infections are a typical complication of chronic lymphocytic leukemia (CLL). Guidelines for prevention of infections in patients with CLL receiving ibrutinib is lacking,...
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years after Gene Therapy with CSL220 (Formerly AMT-060) in Adults with Hemophilia B
Stable Factor IX Expression and Sustained Reductions in Factor IX Use 8 Years after Gene Therapy with CSL220 (Formerly AMT-060) in Adults with Hemophilia B
Introduction: CSL220 (formerly AMT-060) is an adeno-associated virus serotype 5 (AAV5) vector encoding a codon-optimized wild-type human factor IX (FIX) gene, driven by a liver-spe...

